Product Information
CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION is a generic product labeled by Cosette Pharmaceuticals, Inc., priced at $1.4125 per GM under NDC 00713084860. Its NADAC has been published 105 times since Aug 21, 2024.
FDA first approved this application on May 11, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION
calcipotriene and betamethasone dipropionateStrength
.5; 50 mg/g; ug/g
Manufacturer
Cosette Pharmaceuticals, Inc.NDC
00713084860
Classification
Generic
Dosage Form
SUSPENSION
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENEApproval Type
Generic (ANDA)
FDA Application
ANDA210765FDA Approved
5/11/2020
TE Code
AB
On Market Since
8/2/2024
Pharmacological Classes
Price Statistics
The NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION has been published 105 times since Aug 21, 2024, and over the history we have for it it has declined 2.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4125 per GM |
|---|---|
| All-time high | $2.4141 (Jan 14, 2026) |
| All-time low | $1.3005 (Jun 17, 2026) |
| 52-week high | $2.4141 |
| 52-week low | $1.3005 |
| Median price | $1.5088 |
| Average price | $1.7049 |
| Largest weekly change | -17.5% (Apr 22, 2026) |
| Weeks tracked | 105 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION, manufactured by Cosette Pharmaceuticals, Inc., is $1.4125 per GM (NDC 00713084860), effective Aug 19, 2026.
How has the price of CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION changed over time?
Over the history we have for it, the NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION has declined 2.2%. It has been tracked across 105 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION?
Since Aug 21, 2024, the NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION has ranged from a low of $1.3005 (Jun 17, 2026) to a high of $2.4141 (Jan 14, 2026), with a median of $1.5088 per GM.
Are there cheaper alternatives to CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION, is $1.2133 per GM — about 14% below CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION.
Who manufactures CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION?
CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION (NDC 00713084860) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a generic product.